Last Updated：2025/12/06
The continuous erythropoietin receptor activator significantly reduced the frequency of injections required for patients with anemia due to chronic kidney disease.
See correct answer
The continuous erythropoietin receptor activator significantly reduced the frequency of injections required for patients with anemia due to chronic kidney disease.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
